Skip to main content
. Author manuscript; available in PMC: 2012 Jul 29.
Published in final edited form as: J Nucl Med. 2011 Aug 29;52(10):1566–1572. doi: 10.2967/jnumed.111.092924

TABLE 2.

Hepatic 18F-FDGal Kinetics in Absence of Galactose

Subject no. Vmax*/Km* (L blood/min)
Vmax*/(FKm*)
Approximation of Ksyst*toVmax*/Km* Kgal* (L blood/min/L liver tissue)
1 0.41 ± 0.07 0.35 ± 0.06 85% 0.265 ± 0.003
2 0.33 ± 0.03 0.36 ± 0.04 84% 0.213 ± 0.006
3 0.50 ± 0.09 0.29 ± 0.06 87% 0.279 ± 0.004
4 ND ND ND 0.229 ± 0.008
5 0.52 ± 0.09 0.39 ± 0.07 83% 0.342 ± 0.004
6 0.33 ± 0.04 0.35 ± 0.05 84% 0.253 ± 0.004
7 0.24 ± 0.06 0.27 ± 0.06 88% 0.273 ± 0.002
8 0.32 ± 0.06 0.29 ± 0.06 87% 0.295 ± 0.008
Mean ± SE 0.38 ± 0.02 0.33 ± 0.02 85% 0.274 ± 0.001

Vmax*/Km* = intrinsic clearance of 18F-FDGal; F = hepatic blood flow (L blood/min; Table 1); Ksyst* = hepatic systemic clearance of 18F-FDGal; Kgal* = hepatic systemic clearance of 18F-FDGal calculated from PET study without galactose infusion; ND = not determined (in subject 4, no liver vein blood samples were obtained during PET study); mean ± SE = weighted mean ± SE of the weighted mean.

Individual values are given as estimate ± SE of estimate.